Pfizer Q4 Results: $14.25B In Revenue And EPS Of $0.1, Exceeding Forecasts
January 30, 2024 at 09:05 AM EST
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|